FDA BLA · BLA125522
REPATHA
evolocumab
Sponsor: AMGEN INC
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
BLA125522
TYPE
BLA
ORIGINAL APPROVAL
2015-08-27
LATEST ACTION
2026-10-09
ROUTE
SUBCUTANEOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
REPATHAPrescription
EVOLOCUMAB 140MG/ML · INJECTABLE · INJECTION
Approval history
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →